cardiodiagnosticsinc.com (CDIO): Rasio rega marang prakiraan pendapatan
Cardio Diagnostics is implementing precision EpiCheck AI algorithms for autonomous epigenetic DNA analysis. This chart in the GURU.Markets terminal displays the forward P/S indicator, which has captured the metric at 278.00. The company's US-based retail business model minimizes geopolitical risks, although Cardio Diagnostics faces a fierce battle for insurance provider recognition within the growing digital diagnostics sector.
CDIO (cardiodiagnosticsinc.com): rincian analitis lan laporan miturut indikator
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Cardio Diagnostics|CDIO - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Cardio Diagnostics Holdings|CDIO - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Cardio Diagnostics Holdings, Inc.|CDIO - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Cardio Diagnostics|Rasio cepet cardiodiagnosticsinc.com
- rincian asil keuangan lan kelipatan valuasi:
CDIO - Bathi resik|Proyeksi bathi mangsa ngarep Cardio Diagnostics|CDIO - Rasio kapitalisasi marang bathi resik|Rega marang bathi mangsa ngarep Cardio Diagnostics Holdings|CDIO - Rasio P/E diaturake wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cardio Diagnostics Holdings, Inc.|CDIO - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Cardio Diagnostics|CDIO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cardiodiagnosticsinc.com|CDIO - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cardio Diagnostics
- indikator dodolan lan pendapatan:
Ringkesan analisis perusahaan:Cardio Diagnostics Holdings, Inc. CDIO
Forward P/S relates current market capitalization to expected revenue, allowing for a business valuation relative to future cash flows while filtering out market noise. For Cardio Diagnostics (CDIO), this indicator reflects the scaling pace of genetic test sales within preventive medicine clinics, while the forward P/S trend helps determine whether the market price is fair relative to the actual growth in demand for cardiac diagnostics.
Analisis pesaing Cardio Diagnostics
Multiplikator Forward P/S A (Agilent)|Multiplikator Forward P/S Quest Diagnostics Inc. DGX|ILMN - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan EXAS (Exact Sciences Inc.)|RVTY: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan BIO|NNNN (Anbio) - Multiplikator Forward P/S|Sotera Health Corp (SHC) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan QuidelOrtho Corp (QDEL)|OPK - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CareDx, Inc - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan MRVI|Fulgent Genetics - Multiplikator Forward P/S|LAB (Standard BioTools Inc) - Kapitalisasi marang prakiraan pendapatan|CTKB: Multiplikator Forward P/S|OSUR - Rasio kapitalisasi marang dodolan sing dikarepake|XGN (Exagen Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S mdxhealth.com|Multiplikator Forward P/S LUCD|prenetics.com (PRE) - Prakiraan rega marang pendapatan|Rasio rega marang prakiraan pendapatan Insight Molecular Diagnostics Inc IMDX|TRIB: Kapitalisasi marang prakiraan pendapatan|PRPH - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ainos.com|Co-Diagnostics (CODX) - Rasio rega marang prakiraan pendapatan|HSCS - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan BMRA|ONCO (Onconetix Corporation) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S VRAX|Rasio kapitalisasi marang dodolan sing dikarepake bluejaydx.com|Multiplikator Forward P/S AWH (Aspira Women's Health Inc.)|AXDX - Multiplikator forward rega marang pendapatan|CNTG - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Enzo Biochem, Inc. ENZ|FRES: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Genetic Technologies Limited|ME (23andMe) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PMD (Psychemedics Corp.)
